Panda Supplements Skull Nootropic Pre-Workout

Protocol and duration

single acute dose, 40 to 60 minutes before training

Studied context

Studied for resistance-exercise repetition performance/muscular endurance, cycling performance, muscle-damage recovery, and muscle soreness. A 2021 critical review notes a single acute 8 g dose "may, albeit not consistently, increase muscular endurance-strength performance," with a meta-analysis finding an average 6.4% increase in repetitions with 6-8 g dosed 40-60 minutes pre-exercise, with a stronger trend for lower-body than upper-body exercises.

Limitations

The same review states there is "little evidence to advocate its use in the production and maintenance of muscular power, maximal strength, recovery of muscular function, or supporting muscular adaptations," calls cycling-performance effects "scarce," and says claims about reduced muscle soreness lack consistent support. Overall efficacy is called "ambiguous." The review also flags a real-world quality-control problem: commercial products often do not match the citrulline:malate ratio used in the research they cite.

Selected evidence: A critical review of citrulline malate supplementation and exercise performance, 2021 · Open source

Protocol and duration

per day in divided doses, for at least 2 to 4 weeks, not as a single pre-workout dose

Studied context

Studied for high-intensity exercise capacity in the 60-240 second range via elevation of muscle carnosine, which acts as an intracellular pH buffer against acidosis. ISSN 2015 position stand: greatest performance benefits in "open end-point" tasks/time trials lasting 1-4 minutes; some benefit noted in aerobic exercise up to roughly 25 minutes; attenuation of neuromuscular fatigue, particularly noted in older adults.

Limitations

Strength/resistance-training outcomes remain mixed; training volume may increase without a clear strength gain. Tasks under 60 seconds do not show benefit. Endurance benefit beyond about 25 minutes is not established. Long-term safety data beyond roughly a year, and effects in special/tactical populations, are flagged as needing more research.

Selected evidence: ISSN position stand on beta-alanine, 2015 · Open source

Protocol and duration

per day for five days, in the cadet study

Studied context

Studied as the dietary precursor to norepinephrine for mitigating cognitive performance decrements under acute stress. A 2015 Military Medicine evidence review (rapid evidence assessment, 14 trials: 10 RCTs + 4 controlled clinical trials) issued a "weak recommendation" in favor of tyrosine for cognitive stress specifically, stating "all studies showed a positive effect" on that outcome. A widely cited primary study (Deijen et al. 1999, Brain Research Bulletin) gave cadets 2 g tyrosine daily for five days during a combat training course and found better memory and tracking-task performance, plus lower systolic blood pressure, versus a carbohydrate control.

Limitations

The 2015 Military Medicine review states explicitly that "no recommendation could be made" for tyrosine's effect on physical performance under stressful physical conditions, and concludes "available evidence is insufficient to make confident recommendations on the effectiveness of tyrosine for mitigating stress effects on physical/cognitive performance" overall, despite the positive signal on cognition. A separate heat-stress study found tyrosine ingestion did not influence cognitive function or physical performance during exercise heat stress despite raised serum tyrosine. NIH ODS's exercise/athletic-performance fact sheet does not cover tyrosine at all.

Selected evidence: Deijen et al., Brain Research Bulletin, 1999

Protocol and duration

Not recorded in the selected comparison

Studied context

Human data is comparatively sparse. A randomized double-blind placebo-controlled trial studied oral agmatine sulfate (1,335-3,560 mg/day for up to 3 weeks) for lumbar disc-associated radiculopathy (a clinical/pain context, not sports performance). A 2019 Scientific Reports paper examined safety and neurochemical profiles of acute and sub-chronic oral agmatine sulfate treatment.

Limitations

Sports-performance-specific human efficacy data for agmatine sulfate (e.g., a dedicated ISSN position stand) was not located in this research pass. Evidence located centers on safety/tolerability and non-sports clinical contexts rather than an authoritative performance-outcome verdict. Long-term safety in larger populations remains an open gap per the safety literature reviewed.

Selected evidence: Safety and neurochemical profiles of oral agmatine sulfate, 2019 · Open source

Protocol and duration

Adequate Intake for adults, a nutrient reference and not an ergogenic dose

Studied context

NIH ODS's Choline Health Professional fact sheet establishes choline's core physiological roles: synthesis of phosphatidylcholine and sphingomyelin for cell-membrane structure, acetylcholine (a neurotransmitter for memory, mood, and muscle control) production, methyl-group donation, gene-expression modulation, and brain development. Choline bitartrate is named as one of three supplement forms (with phosphatidylcholine and lecithin).

Limitations

NIH ODS states explicitly: "No studies have compared the relative bioavailability of choline from these different forms". Meaning choline bitartrate's absorption/efficacy relative to phosphatidylcholine, lecithin, or non-bitartrate forms (like alpha-GPC) is not established by NIH's own review.

Selected evidence: NIH ODS, Choline fact sheet · Open source

Protocol and duration

Not recorded in the selected comparison

Studied context

EFSA's Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), in its 2017 opinion on xanthine alkaloids from the flavoring priority list, treats theobromine as a major metabolite of caffeine. Roughly 11% of an ingested caffeine dose converts systemically to theobromine. And states that because "only limited toxicity data in humans are available" for theobromine directly, its safety assessment leans on the extensive caffeine safety literature (EFSA's 2015 caffeine opinion) rather than an independent human-efficacy dataset for theobromine as a standalone ergogenic ingredient.

Limitations

No sports-performance-specific position stand or ISSN evaluation of theobromine as a standalone ergogenic ingredient was located in this research pass. EFSA's own framing acknowledges limited independent human toxicity data on theobromine itself.

Selected evidence: EFSA Flavouring Group Evaluation 49 Revision 1, 2017 · Open source

Protocol and duration

per day across trials, with most using 200 mg

Studied context

Studied for attention/reaction-time measures and for stress-related relaxation without sedation. A meta-analysis/systematic review of 31 randomized controlled trials (n=1,168) found a single 200 mg dose taken 30-60 minutes before testing significantly improved choice reaction time (SMD = 0.51, 95% CI 0.25-0.77); a subset of 5 RCTs in 148 healthy adults found a dose-dependent effect on rapid visual information processing and recognition visual reaction time.

Limitations

The review describing itself as "promising, but not completely conclusive" signals the overall evidence base has not reached firm consensus strength despite the positive reaction-time finding.

Selected evidence: Systematic review and meta-analysis of L-theanine on cognitive performance · Open source